You are here

Asia Green Biotechnology Corp.

Asia Green Biotechnology Corp. logo
Listing Exchange: 
CSE
Status: 
Halted Pending Fundamental Change
Industry: 
Life Sciences
Symbol: 
ASIA
CSE Index: 
Currency: 

Asia Green is an early stage international bio-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities under the terms of license agreements with InPlanta Biotechnology Ltd., Swysh Inc. and Pathway RX Inc.

You are here

Asia Green Biotechnology Corp. (ASIA)

SEDAR Information

Company Info

Address
SUITE 1150, 707 - 7 AVENUE SW
Calgary
CALGARY, AB T2P 3H6
Canada
Phone
403-863-6034
Email
[email protected]
Website
http://asiacannabiscorp.com
Listing date
Thursday, January 24, 2019
Transfer Agent
TSX Trust Company
Email
[email protected]

Capitalization

Issued & Outstanding: 
36247100
Reserved for Issuance: 
250000

Company Officers

David E. T. Pinkman, President and Chief Executive Officer
Alisdair Leeson, Chief Financial Officer

News Releases

Bulletins

28/02/2024

2024-0234 - Halted for Fundamental Change - Asia Green Biotechnology Corp. (ASIA)

le 28 février/February 2024

Trading in the shares of Asia Green Biotechnology Corp. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Acquisition pursuant to CSE Policy 8. This regulatory halt is imposed by Canadian Investment Regulatory Organization, the Market Regulator of the Exchange, pursuant to the provisions of Section 10.9(1) of the Universal Market Integrity Rules.